Janina Kaislasuo1,2, Samantha Simpson1, Jesper F Petersen3, Gang Peng4, Paulomi Aldo1, Ellen Lokkegaard3, Michale Paidas5, Lubna Pal1, Seth Guller1, Gil Mor1,6. 1. Division of Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA. 2. Department of Obstetrics and Gynecology, University of Helsinki and The Helsinki University Hospital, Helsinki, Finland. 3. Department of Obstetrics and Gynecology, North Zealand Hospital, Hilleroed, Denmark. 4. Department of Biostatistics, School of Public Health, Yale University, New Haven, CT, USA. 5. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. 6. Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, Wayne State University, Detroit, MI, USA.
Abstract
PROBLEM: Embryo implantation and placentation require a careful immunological balance. Cytokines such as IL-10 and TNFα have been implicated as markers of dysregulation, but have only been studied at a single time point or after a pregnancy loss. Our objective was to determine normative patterns of serum levels of IL-10 and TNFα and their ratio throughout the first trimester in healthy pregnancies and to determine if this pattern differs from pregnancy loss. METHOD OF STUDY: Two prospective longitudinal cohorts of gravidae including in vitro fertilization (IVF) and naturally conceived pregnancies with serial blood draws. Cytokines were assayed using Simple Plex. In the IVF cohort, we monitored from the implantation day up to 6 weeks of gestation; whereas in the naturally conceived cohort, sample collection began at 4 weeks and throughout the whole first trimester. RESULTS: IL-10 concentrations in normal pregnancies were significantly higher than in pregnancies ending in a loss starting at 6-8 weeks of gestation, while TNFα concentrations were significantly lower in normal than in pregnancies ending in a loss starting at 3-5 of gestation weeks. The IL-10 to TNFα ratio in normal pregnancies was significantly higher from 4 to 9 weeks compared to pregnancies that were lost (t test, P < .05). Changes were observed before any symptoms of miscarriage were present. CONCLUSION: We provide evidences of differences in early immunomodulation in healthy pregnancies vs those destined to end in first-trimester loss. The ratio of IL-10 to TNFα rises significantly higher in viable pregnancies as early as 4.5 weeks compared to pregnancies loss.
PROBLEM: Embryo implantation and placentation require a careful immunological balance. Cytokines such as IL-10 and TNFα have been implicated as markers of dysregulation, but have only been studied at a single time point or after a pregnancy loss. Our objective was to determine normative patterns of serum levels of IL-10 and TNFα and their ratio throughout the first trimester in healthy pregnancies and to determine if this pattern differs from pregnancy loss. METHOD OF STUDY: Two prospective longitudinal cohorts of gravidae including in vitro fertilization (IVF) and naturally conceived pregnancies with serial blood draws. Cytokines were assayed using Simple Plex. In the IVF cohort, we monitored from the implantation day up to 6 weeks of gestation; whereas in the naturally conceived cohort, sample collection began at 4 weeks and throughout the whole first trimester. RESULTS: IL-10 concentrations in normal pregnancies were significantly higher than in pregnancies ending in a loss starting at 6-8 weeks of gestation, while TNFα concentrations were significantly lower in normal than in pregnancies ending in a loss starting at 3-5 of gestation weeks. The IL-10 to TNFα ratio in normal pregnancies was significantly higher from 4 to 9 weeks compared to pregnancies that were lost (t test, P < .05). Changes were observed before any symptoms of miscarriage were present. CONCLUSION: We provide evidences of differences in early immunomodulation in healthy pregnancies vs those destined to end in first-trimester loss. The ratio of IL-10 to TNFα rises significantly higher in viable pregnancies as early as 4.5 weeks compared to pregnancies loss.
Authors: Jiahui Ding; Anthony Maxwell; Nicholas Adzibolosu; Anna Hu; Yuan You; Aihua Liao; Gil Mor Journal: Immunol Rev Date: 2022-03-20 Impact factor: 10.983
Authors: Yuan You; Patrick Stelzl; Dana N Joseph; Paulomi B Aldo; Anthony J Maxwell; Nava Dekel; Aihua Liao; Shannon Whirledge; Gil Mor Journal: Front Immunol Date: 2021-11-01 Impact factor: 7.561
Authors: Andrea E Cassidy-Bushrow; Charlotte Burmeister; Johnna Birbeck; Yalei Chen; Lois Lamerato; Lawrence D Lemke; Jia Li; Gil Mor; Brendan F O'Leary; Rosalind M Peters; John J Reiners; F Gianluca Sperone; Judy Westrick; Evan Wiewiora; Jennifer K Straughen Journal: J Reprod Immunol Date: 2021-03-09 Impact factor: 3.993
Authors: Andrea Trombetta; Manola Comar; Alberto Tommasini; Melania Canton; Giuseppina Campisciano; Nunzia Zanotta; Carolina Cason; Gianpaolo Maso; Francesco Maria Risso Journal: Int J Environ Res Public Health Date: 2021-03-17 Impact factor: 3.390